Nabil G Seidah
Nabil G Seidah is an expert in Biochemistry at Montreal Clinical Research Institute (Canada). Nabil G Seidah has authored 766 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,967 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Oncology - Endocrinology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1974 - 2026
Number : 766
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Is FH a curable disease? PMID 42798794 | Glob Cardiol Sci Pract | 2026 | 0 |
| The secretory PCSK family in cardiovascular disease and beyond. PMID 42297531 — cells, growth, macrophages, proprotein convertases, cardiovascular diseases, peptide hydrolases | Atherosclerosis | 2026 | 0 |
| PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. PMID 42288054 | J Lipid Res | 2026 | 0 |
| Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights. PMID 41807234 — cells, hypobetalipoproteinemias, lipoproteins, cholesterol, apolipoproteins b | J Clin Lipidol | 2026 | 0 |
| Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print]. PMID 42025556 — apolipoproteins b | J Clin Lipidol | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map